These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 3295924)
1. [Current theories on the etiopathogenesis and treatment of Alzheimer's disease]. Bidzan L Psychiatr Pol; 1986; 20(5):377-85. PubMed ID: 3295924 [No Abstract] [Full Text] [Related]
2. [Progress in the studies of the etiology and treatment of Alzheimer's disease]. Jarema M Wiad Lek; 1988 Jun; 41(11):717-23. PubMed ID: 3070943 [No Abstract] [Full Text] [Related]
3. [Cholinergic treatment strategies in Alzheimer's disease]. Kurz A; Rüster P; Romero B; Zimmer R Nervenarzt; 1986 Oct; 57(10):558-69. PubMed ID: 3785472 [No Abstract] [Full Text] [Related]
4. [Etiopathogenesis and treatment of Alzheimer's disease]. Kanios K Wiad Lek; 1986 Jan; 39(2):101-5. PubMed ID: 3014757 [No Abstract] [Full Text] [Related]
6. The mechanisms of neurodegenerative processes and current pharmacotherapy of Alzheimer's disease. Gongadze N; Antelava N; Kezeli T; Okudjava M; Pachkoria K Georgian Med News; 2008 Feb; (155):44-8. PubMed ID: 18401056 [TBL] [Abstract][Full Text] [Related]
7. [Cholinergic mechanisms in the brain and their impairment in Alzheimer's disease]. Tucek S Cesk Psychiatr; 1987 Feb; 83(1):36-45. PubMed ID: 3581254 [No Abstract] [Full Text] [Related]
8. Alzheimer's disease as copper deficiency. Klevay LM Med Hypotheses; 2008; 70(4):802-7. PubMed ID: 17928161 [TBL] [Abstract][Full Text] [Related]
10. [Use of cholinesterase inhibitors in Alzheimer disease]. Sampalmieri M; Troiani MP; Servi M Clin Ter; 1993 Dec; 143(6):549-52. PubMed ID: 8306579 [TBL] [Abstract][Full Text] [Related]
11. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Hardy J; Selkoe DJ Science; 2002 Jul; 297(5580):353-6. PubMed ID: 12130773 [TBL] [Abstract][Full Text] [Related]
12. The role of the p75 neurotrophin receptor in cholinergic dysfunction in Alzheimer's disease. Coulson EJ; May LM; Sykes AM; Hamlin AS Neuroscientist; 2009 Aug; 15(4):317-23. PubMed ID: 19458382 [TBL] [Abstract][Full Text] [Related]
13. NGF and the treatment of Alzheimer's disease. Olson L Exp Neurol; 1993 Nov; 124(1):5-15. PubMed ID: 8282080 [TBL] [Abstract][Full Text] [Related]
14. [Current concepts on the hypothesis of the cholinergic etiology of Alzheimer's disease ]. Coralli MV; Zanotti E; Salsi A Recenti Prog Med; 1986 Sep; 77(9):436-9. PubMed ID: 3541087 [No Abstract] [Full Text] [Related]
15. [Alterations in cholinergic and adrenergic receptors in senile dementia of the Alzheimer's-type]. Shimohama S; Kameyama M Rinsho Shinkeigaku; 1986 Dec; 26(12):1294-7. PubMed ID: 3030597 [No Abstract] [Full Text] [Related]
16. [Inflammatory mechanisms in the pathogenesis of Alzheimer's disease]. Verbeek MM; Otte-Höller I; Ruiter DJ; de Waal RM Tijdschr Gerontol Geriatr; 1997 Oct; 28(5):213-8. PubMed ID: 9526791 [TBL] [Abstract][Full Text] [Related]
17. Omental transposition in treatment of Alzheimer disease. Goldsmith HS J Am Coll Surg; 2007 Dec; 205(6):800-4. PubMed ID: 18035264 [No Abstract] [Full Text] [Related]
18. Nerve growth factor pharmacology: application to the treatment of cholinergic neurodegeneration in Alzheimer's disease. Lapchak PA Exp Neurol; 1993 Nov; 124(1):16-20. PubMed ID: 8282073 [TBL] [Abstract][Full Text] [Related]